<html><head></head><body><h1>Isoxsuprine Hydrochloride</h1><p class="drug-subtitle"><b>Dosage Form:</b> tablet<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Professional</li>
<li>Interactions</li>
<li>Reviews</li>
<li>Images</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li>Warnings</li>
<li>Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx Only</span></p><h2>Isoxsuprine Hydrochloride Description</h2><p class="First">Each tablet taken orally contains Isoxsuprine Hydrochloride, USP with the following chemical structure:</p><p></p><p>C<span class="Sub">18</span>H<span class="Sub">23</span>NO<span class="Sub">3</span> • HCl</p><p>p-Hydroxy-α[1-[(methyl-2-phenoxy-ethyl)amino]ethyl]benzyl alcohol hydrochloride.</p><h3>Quantitative Ingredient Information</h3><p class="First">Each tablet taken orally contains 10 or 20 mg Isoxsuprine HCl</p><h3>Pharmacological Class</h3><p class="First">Peripheral Vasodilator</p><h2>INDICATIONS</h2><p class="First">Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:</p><p>Possibly Effective:</p><p>Final classification of the less-than-effective indications requires further investigation.</p><h2>Contraindications</h2><p class="First">There are no known contraindications to oral use when administered in recommended doses.</p><p>Isoxsuprine Hydrochloride, USP should not be given immediately postpartum or in the presence of arterial bleeding.</p><h2>Precautions</h2><h3>Pediatric Use</h3><p class="First">Safety and effectiveness in pediatric patients have not been established.</p><h2>Adverse Reactions</h2><p class="First">On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.</p><p>Although available evidence suggests a temporal association of these reactions with Isoxsuprine Hydrochloride, a causal relationship can be neither confirmed nor refuted.</p><p>Beta Adrenergic receptor stimulants such as Isoxsuprine Hydrocholoride have been used to inhibit pre-term labor.</p><p>Maternal and fetal tachycardia may occur under such use. Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received Isoxsuprine Hydrochloride. Pulmonary edema has been reported in mothers treated with beta stimulants. Isoxsuprine Hydrochloride is neither approved nor recommended for use in the treatment of premature labor.</p><p class="First">Keep this and all medications out of the reach of children.</p><h2>Isoxsuprine Hydrochloride Dosage and Administration</h2><p class="First">Oral: 10 to 20 mg, three or four times daily.For additional dosage recommendations, and other important prescribing information, see accompanying package insert.</p><h2>How is Isoxsuprine Hydrochloride Supplied</h2><p class="First">Isoxsuprine HCl tablets, USP 10 mg<br/>
Bottles of 100 NDC 42582-101-10</p><p>Isoxsuprine HCl tablets, USP 20 mg<br/>
Bottles of 100 NDC 42582-201-10</p><p>Isoxsuprine HCl tablets, USP 20 mg<br/>
Bottles of 1000 NDC 42582-201-20</p><h3>COMPOSITION</h3><p class="First">Isoxsuprine HCl 10mg and 20mg tablets: These tablets contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate (vegetable), microcrystalline cellulose.</p><p class="First"><span class="Bold">Distributed By:<br/>
Bi-Coastal Pharma International LLC</span><br/>
<span class="Bold">Red Bank, NJ 07701</span></p><p>Iss. 11/14</p><h2>COMPOSITION</h2><p class="First">lsoxsuprine HCI 10mg and 20mg tablets:</p><p><br/>
These tablets contain the fdlowing inactive ingredients: lactose monohydrate, magnesium stearate, microcrystalline cellulose.</p><h2>Storage and Handling</h2><p class="First">Store between 15° and 20°C (59° and 86°F).</p><p><br/>
Keep container tightly closed. Dispense in a tight container as defined in the USP.</p><h2>Distributed By:</h2><p class="First">Bi-Coastal Pharma International LLC, Red Bank, NJ 07701</p><h2>Manufactured By:</h2><p class="First">Syntho Pharmaceuticals, Inc.<br/>
Farmingdale, NY 11735<br/>
Rev. 05/19</p><p><br/>
MADE IN U.S.A.</p><h2>PRINCIPAL DISPLAY PANEL - 10 mg Bottle Label</h2><p class="First">Syntho</p><p>NDC 66576-201-10</p><p><span class="Bold">Isoxsuprine Hydrochloride Tablets, USP</span></p><p><span class="Bold">20 mg</span></p><p><span class="Bold">Rx only</span></p><p><span class="Bold">100 Tablets</span></p><p></p><h2>More about isoxsuprine</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: peripheral vasodilators</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Isoxsuprine Oral, Injection &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Raynaud's Syndrome</li>
<li>Cerebrovascular Insufficiency</li>
<li>Coronary Artery Disease</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>